SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-209106
Filing Date
2023-08-10
Accepted
2023-08-10 16:39:19
Documents
7
Effectiveness Date
2023-08-10

Document Format Files

Seq Description Document Type Size
1 S-8 d815321ds8.htm S-8 56613
2 EX-5.1 d815321dex51.htm EX-5.1 4628
3 EX-23.1 d815321dex231.htm EX-23.1 1473
4 EX-99.1 d815321dex991.htm EX-99.1 67033
5 EX-99.2 d815321dex992.htm EX-99.2 18192
6 EX-99.3 d815321dex993.htm EX-99.3 31317
7 EX-FILING FEES d815321dexfilingfees.htm EX-FILING FEES 16003
  Complete submission text file 0001193125-23-209106.txt   196231
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273883 | Film No.: 231160205
SIC: 2834 Pharmaceutical Preparations